Related references
Note: Only part of the references are listed.Stereologic investigation of the posterior part of the hippocampus in schizophrenia
Andrea Schmitt et al.
ACTA NEUROPATHOLOGICA (2009)
Dopamine-glutamate abnormalities in the frontal cortex associated with the catechol-O-methyltransferase (COMT) in schizophrenia
Ralf Brisch et al.
BRAIN RESEARCH (2009)
ErbB receptors and the development of the nervous system
Carmen Birchmeier
EXPERIMENTAL CELL RESEARCH (2009)
Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis
Daniel Martins-de-Souza et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
Meta-analysis of diffusion tensor imaging studies in schizophrenia
Ian Ellison-Wright et al.
SCHIZOPHRENIA RESEARCH (2009)
The risk for schizophrenia from childhood and adult infections
Alan S. Brown
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Microglia Activation in Recent-Onset Schizophrenia: A Quantitative (R)-[11C]PK11195 Positron Emission Tomography Study
Bart N. van Berckel et al.
BIOLOGICAL PSYCHIATRY (2008)
Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys
Glenn T. Konopaske et al.
BIOLOGICAL PSYCHIATRY (2008)
Inflammatory cytokine alterations in schizophrenia: A systematic quantitative review
Stephane Potvin et al.
BIOLOGICAL PSYCHIATRY (2008)
The astrocyte surface NAAG receptor and NAAG peptidase signaling complex as a therapeutic target
Morris H. Baslow
DRUG NEWS & PERSPECTIVES (2008)
Insulin-like growth factor system regulates oligodendroglial cell behavior: Therapeutic potential in CNS
Daniel Chesik et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2008)
Polymorphisms of Transferrin gene are associated with schizophrenia in Chinese Han population
Mei Qu et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: A morphometric study
Johann Steiner et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
Immunological aspects in the neurobiology of suicide: Elevated microglial density in schizophrenia and depression is associated with suicide
Johann Steiner et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders
Jacques De Keyser et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency
Siming Shen et al.
NATURE NEUROSCIENCE (2008)
Remyelination in the CNS: from biology to therapy
Robin J. M. Franklin et al.
NATURE REVIEWS NEUROSCIENCE (2008)
S100B is expressed in, and released from, OLN-93 oligodendrocytes: Influence of serum and glucose deprivation
J. Steiner et al.
NEUROSCIENCE (2008)
Neuron-Astrocyte Signaling in the Development and Plasticity of Neural Circuits
Beth Stevens
NEUROSIGNALS (2008)
A family-based association study of the myelin-associated glycoprotein and 2,T-cyclic nucleotide 3'-phosphodiesterase genes with schizophrenia
Aristotle N. Voineskos et al.
PSYCHIATRIC GENETICS (2008)
Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia
Amy E. Steffek et al.
SCHIZOPHRENIA RESEARCH (2008)
Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia
Shruti N. Mitkus et al.
SCHIZOPHRENIA RESEARCH (2008)
Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients
Victor Z. Chong et al.
SCHIZOPHRENIA RESEARCH (2008)
Cytokines and Myelination in the Central Nervous System
Thomas Schmitz et al.
THESCIENTIFICWORLDJOURNAL (2008)
Deficit of pericapillary oligodendrocytes in the prefrontal cortex in schizophrenia
Victor Vostrikov et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2008)
Cerebral disconnectivity:: an early event in schizophrenia
S. Begre et al.
NEUROSCIENTIST (2008)
Compromised myelin integrity during psychosis with repair during remission in drug-responding schizophrenia
David L. Garver et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)
Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes
L. Xiao et al.
MOLECULAR PSYCHIATRY (2008)
The myelin-pathogenesis puzzle in schizophrenia: a literature review
G. Karoutzou et al.
MOLECULAR PSYCHIATRY (2008)
Disturbed structural connectivity in schizophrenia - Primary factor in pathology or epiphenomenon?
Andreas Konrad et al.
SCHIZOPHRENIA BULLETIN (2008)
A possible link between dopamine action and myelin dysfunction in schizophrenia
Eva Lindholm et al.
SCHIZOPHRENIA RESEARCH (2007)
Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia
Jean Theberge et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
Inflammation-related genes up-regulated in schizophrenia brains
Peter Saetre et al.
BMC PSYCHIATRY (2007)
Tryptophan breakdown pathway in bipolar mania
Aye Mu Myint et al.
JOURNAL OF AFFECTIVE DISORDERS (2007)
Deficit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders
Victor M. Vostrikov et al.
SCHIZOPHRENIA RESEARCH (2007)
The role of oligodendrocyte pathology in schizophrenia
Natalya A. Uranova et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)
Further evidence for altered myelin biosynthesis and glutamatergic dysfunction in schizophrenia
Dmitri Tkachev et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)
Oligodendroglial abnormalities in schizophrenia, mood disorders and substance abuse. Comorbidity, shared traits, or molecular phenocopies?
Boris P. Sokolov
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)
White matter and cognitive function in schizophrenia
Andrew J. Dwork et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)
Myelin staining of deep white matter in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and unipolar major depression
William T. Regenold et al.
PSYCHIATRY RESEARCH (2007)
Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders
Kristine Roy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Antibodies to Toxoplasma gondii in patients with schizophrenia:: A meta-analysis
E. Fuller Torrey et al.
SCHIZOPHRENIA BULLETIN (2007)
The association between exposure to COX-2 inhibitors and schizophrenia deterioration. A nested case-control study
P. Stolk et al.
PHARMACOPSYCHIATRY (2007)
Restoration of FcRγ/Fyn signaling repairs central nervous system demyelination
Chika Seiwa et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia
Robert E. McCullumsmith et al.
SCHIZOPHRENIA RESEARCH (2007)
Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial
Shahin Akhondzadeh et al.
SCHIZOPHRENIA RESEARCH (2007)
Possible antipsychotic effects of minocycline in patients with schizophrenia
Tsuyoshi Miyaoka et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Evidence for a wide extra-astrocytic distribution of S100B in human brain
Johann Steiner et al.
BMC NEUROSCIENCE (2007)
The ultrastructure of lymphocytes in schizophrenia
Natalya Uranova et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2007)
How do glial-neuronal interactions fit into current neurotransmitter hypotheses of schizophrenia?
Daniel Kondziella et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Nogo A, B and C expression in schizophrenia, depression and bipolar frontal cortex, and correlation of Nogo expression with CAA/TATC polymorphism in 3′-UTR
Gabriela Novak et al.
BRAIN RESEARCH (2006)
Maternal immune activation during pregnancy increases limbic GABAA receptor immunoreactivity in the adult offspring:: Implications for schizophrenia
M. Nyffeler et al.
NEUROSCIENCE (2006)
Cytokines in schizophrenia and the effects of antipsychotic drugs
Lukasz Drzyzga et al.
BRAIN BEHAVIOR AND IMMUNITY (2006)
Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder
Carla T. Toro et al.
NEUROSCIENCE LETTERS (2006)
Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization
Johann Steiner et al.
ACTA NEUROPATHOLOGICA (2006)
Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia
Lyudmila Georgieva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Cytosolic prostaglandin E2 synthase (cPGES) expression is decreased in discrete cortical regions in psychiatric disease
Mary E. Maida et al.
BRAIN RESEARCH (2006)
Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia
Chang-Gyu Hahn et al.
NATURE MEDICINE (2006)
Schizophrenia-associated reduction of neuronal and oligodendrocyte numbers in the anterior principal thalamic nucleus
William Byne et al.
SCHIZOPHRENIA RESEARCH (2006)
Alterations of white matter connectivity in first episode schizophrenia
Andrea Federspiel et al.
NEUROBIOLOGY OF DISEASE (2006)
Localization of neuregulin-1α (heregulin-α) and one of its receptors, ErbB-4 tyrosine kinase, in developing and adult human brain
Hans-Gert Bernstein et al.
BRAIN RESEARCH BULLETIN (2006)
Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia
Karolina Aberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients
S Dracheva et al.
NEUROBIOLOGY OF DISEASE (2006)
Human QKI, a new candidate gene for schizophrenia involved in myelination
K Åberg et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2006)
Schizophrenia susceptibility genes converge on interlinked pathways related to glutamatergic transmission and long-term potentiation, oxidative stress and oligodendrocyte viability
C. J. Carter
SCHIZOPHRENIA RESEARCH (2006)
Neuropathological, neurogenetic and neuroimaging evidence for white matter pathology in schizophrenia
Mark Walterfang et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2006)
Cytomegalovirus. and schizophrenia
E. Fuller Torrey et al.
CNS DRUGS (2006)
Convergent evidence for 2 ',3 '-cyclic nucleotide 3 '-phosphodiesterase as a possible susceptibility gene for schizophrenia
TR Peirce et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Dopamine D2 and D3 receptor agonists limit oligodendrocyte injury caused by glutamate oxidative stress and oxygen/glucose deprivation
C Rosin et al.
GLIA (2005)
Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: A gene ontology study
P Katsel et al.
SCHIZOPHRENIA RESEARCH (2005)
The association of the HLA in patients with schizophrenia, schizoaffective disorder, and in their biological relatives
SOV Nunes et al.
SCHIZOPHRENIA RESEARCH (2005)
Celecoxib augmentation of continuously Ill patients with schizophrenia
MH Rapaport et al.
BIOLOGICAL PSYCHIATRY (2005)
Increased expression of glutaminase and glutamine synthetase mRNA in the thalamus in schizophrenia
EG Bruneau et al.
SCHIZOPHRENIA RESEARCH (2005)
Clinical effects of COX-2 inhibitors on cognition in schizophrenia
N Müller et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2005)
Evidence for white matter abnormalities in schizophrenia
M Kubicki et al.
CURRENT OPINION IN PSYCHIATRY (2005)
Genetic study of the myelin oligodendrocyte glycoprotein (MOG) gene in schizophrenia
G Zai et al.
GENES BRAIN AND BEHAVIOR (2005)
Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients
Kenji Hashimoto et al.
BMC PSYCHIATRY (2005)
Immunological aetiology of major psychiatric disorders - Evidence and therapeutic implications
B Sperner-Unterweger
DRUGS (2005)
The immunology of psychiatric disorders
V Arolt et al.
PSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE (2005)
Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia
MJ Webster et al.
NEUROSCIENCE (2005)
Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium
NA Uranova et al.
SCHIZOPHRENIA RESEARCH (2004)
Cytokine networks in patients with schizophrenia and their possible role in its pathophysiology
A Schuld et al.
NERVENARZT (2004)
COX-2 inhibition as a treatment approach in schizophrenia:: Immunological considerations and clinical effects of celecoxib add-on therapy
N Müller et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2004)
Microarray analysis of postmortem temporal cortex from patients with schizophrenia
C Aston et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2004)
The problem of astrocyte identity
HK Kimelberg
NEUROCHEMISTRY INTERNATIONAL (2004)
Altered myelination of the hippocampal formation in subjects with schizophrenia and bipolar disorder
JS Chambers et al.
NEUROCHEMICAL RESEARCH (2004)
Rheumatoid arthritis and schizophrenia: a negative association at a dimensional level
P Gorwood et al.
SCHIZOPHRENIA RESEARCH (2004)
Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia
G Corfas et al.
NATURE NEUROSCIENCE (2004)
Oligodendrocyte dysfunction in schizophrenia and bipolar disorder
D Tkachev et al.
LANCET (2003)
Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia
PR Hof et al.
BIOLOGICAL PSYCHIATRY (2003)
White matter changes in schizophrenia - Evidence for myelin-related dysfunction
KL Davis et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Herpesviruses and Toxoplasma gondii in orbital frontal cortex of psychiatric patients
C Conejero-Goldberg et al.
SCHIZOPHRENIA RESEARCH (2003)
Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins
SW Flynn et al.
MOLECULAR PSYCHIATRY (2003)
Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia
G Rajkowska et al.
SCHIZOPHRENIA RESEARCH (2002)
Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia
PR Hof et al.
NEUROCHEMICAL RESEARCH (2002)
Why does remyelination fail in multiple sclerosis?
RJM Franklin
NATURE REVIEWS NEUROSCIENCE (2002)
Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia
N Müller et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Glial cell abnormalities in major psychiatric disorders: The evidence and implications
DR Cotter et al.
BRAIN RESEARCH BULLETIN (2001)
A quantitative immunohistochemical study of astrocytes in the entorhinal cortex in schizophrenia, bipolar disorder and major depression: Absence of significant astrocytosis
R Damadzic et al.
BRAIN RESEARCH BULLETIN (2001)
Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia
Y Hakak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Glia: Listening and talking to the synapse
PG Haydon
NATURE REVIEWS NEUROSCIENCE (2001)
Expression of CD40 in the brain of Alzheimer's disease and other neurological diseases
T Togo et al.
BRAIN RESEARCH (2000)
Absence of neurodegeneration in the thalamus and caudate of elderly patients with schizophrenia
E Falke et al.
PSYCHIATRY RESEARCH (2000)
Share Paper
